CTI BioPharma (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot FDA News Momentum Movers Trader Talk

CTI BioPharma (CTIC) PT Raised to $12 at Brookline Capital Markets Following FDA ApprovalMarch 1, 2022 10:13 AM Stifel Reiterates Buy Rating on CTI BioPharma (CTIC), Expects Stock to Trade Up Substantially on Vonjo ApprovalMarch 1, 2022 6:41 AM CTI BioPharma (CTIC) Granted FDA Accelerated Approval of VONJOMarch 1, 2022 6:01 AM CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and ThrombocytopeniaFebruary 28, 2022 7:18 PM